Lee Roy Mitchell
Insider
First SEC filing: April 23, 2007 · Latest: April 23, 2007
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 15, 2020 | CNK | A | 48,726 | · | · | 5,756,936 Direct | +0.85% | Acquired | (price as of 2026-10-02) |
| March 17, 2020 | CNK | P | 122,800 | $7.94 | $975,032 | 5,708,210 Direct | +2.20% | Acquired | 354.0% (price as of 2026-10-02) |
| March 16, 2020 | CNK | P | 106,860 | $9.30 | $993,798 | 5,585,410 Direct | +1.95% | Acquired | 287.6% (price as of 2026-10-02) |
| March 16, 2020 | CNK | P | 106,001 | $9.30 | $985,809 | 5,584,551 Direct | +1.93% | Acquired | 287.6% (price as of 2026-10-02) |
| Feb. 26, 2020 | CNK | P | 74,800 | $26.71 | $1,997,908 | 5,478,550 Direct | +1.38% | Acquired | 35.0% (price as of 2026-10-02) |
| Dec. 14, 2017 | CNK | S | 37,069 | $36.02 | $1,335,225 | 5,403,750 Direct | -0.68% | Disposed | 0.1% (price as of 2026-10-02) |
| Dec. 13, 2017 | CNK | S | 88,024 | $36.04 | $3,172,385 | 5,440,819 Direct | -1.59% | Disposed | 0.0% (price as of 2026-10-02) |
| Dec. 12, 2017 | CNK | S | 174,607 | $36.72 | $6,411,569 | 5,528,843 Direct | -3.06% | Disposed | -1.8% (price as of 2026-10-02) |
| Dec. 5, 2017 | CNK | S | 300 | $35.95 | $10,785 | 5,703,450 Direct | -0.01% | Disposed | 0.3% (price as of 2026-10-02) |
| Dec. 19, 2011 | TCBIO | M | 4,000 | $7.25 | $29,000 | 219,518 Direct | +1.86% | Acquired | 160.7% (price as of 2026-10-02) |
| Dec. 19, 2011 | TCBIO | M | 4,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| May 13, 2011 | CNK | S | 1,000,000 | $20.70 | $20,700,000 | 4,419,095 Indirect | -18.45% | Disposed | 74.2% (price as of 2026-10-02) |
| May 13, 2011 | CNK | S | 1,000,000 | $20.70 | $20,700,000 | 5,703,750 Direct | -14.92% | Disposed | 74.2% (price as of 2026-10-02) |
| Nov. 23, 2010 | TCBIO | M | 4,000 | $7.25 | $29,000 | 215,518 Direct | +1.89% | Acquired | 160.7% (price as of 2026-10-02) |
| Nov. 23, 2010 | TCBIO | M | 4,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| May 18, 2010 | TCBIO | A | 1,000 | · | · | 1,000 Direct | · | Acquired | (price as of 2026-10-02) |
| May 18, 2010 | TCBIO | A | 3,000 | · | · | 3,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 10, 2010 | CNK | S | 1,000,000 | $16.98 | $16,980,000 | 5,419,095 Indirect | -15.58% | Disposed | 112.3% (price as of 2026-10-02) |
| May 19, 2009 | TCBIO | A | 3,000 | · | · | 3,000 Direct | · | Acquired | (price as of 2026-10-02) |
| May 19, 2009 | TCBIO | A | 1,000 | · | · | 3,000 Direct | +50.00% | Acquired | (price as of 2026-10-02) |
| May 19, 2008 | TCBIO | A | 3,000 | · | · | 7,000 Direct | +75.00% | Acquired | (price as of 2026-10-02) |
| May 19, 2008 | TCBIO | A | 1,000 | · | · | 21,200 Direct | +4.95% | Acquired | (price as of 2026-10-02) |
| May 19, 2008 | TCBIO | A | 2,000 | · | · | 6,000 Direct | +50.00% | Acquired | (price as of 2026-10-02) |
| May 19, 2008 | TCBIO | A | 500 | · | · | 20,700 Direct | +2.48% | Acquired | (price as of 2026-10-02) |
| March 13, 2008 | CNK | P | 800 | $13.50 | $10,800 | 6,703,750 Direct | +0.01% | Acquired | 167.0% (price as of 2026-10-02) |
| March 13, 2008 | CNK | P | 300 | $13.49 | $4,047 | 6,702,950 Direct | 0.00% | Acquired | 167.2% (price as of 2026-10-02) |
| March 11, 2008 | CNK | P | 500 | $13.49 | $6,745 | 6,702,650 Direct | +0.01% | Acquired | 167.2% (price as of 2026-10-02) |
| March 11, 2008 | CNK | P | 500 | $13.48 | $6,740 | 6,702,150 Direct | +0.01% | Acquired | 167.4% (price as of 2026-10-02) |
| March 11, 2008 | CNK | P | 900 | $13.45 | $12,105 | 6,701,650 Direct | +0.01% | Acquired | 168.0% (price as of 2026-10-02) |
| March 11, 2008 | CNK | P | 100 | $13.44 | $1,344 | 6,700,750 Direct | 0.00% | Acquired | 168.2% (price as of 2026-10-02) |
| March 11, 2008 | CNK | P | 1,000 | $13.43 | $13,430 | 6,700,650 Direct | +0.01% | Acquired | 168.4% (price as of 2026-10-02) |
| March 11, 2008 | CNK | P | 300 | $13.42 | $4,026 | 6,699,650 Direct | 0.00% | Acquired | 168.6% (price as of 2026-10-02) |
| March 11, 2008 | CNK | P | 600 | $13.41 | $8,046 | 6,699,350 Direct | +0.01% | Acquired | 168.8% (price as of 2026-10-02) |
| Nov. 15, 2007 | CNK | P | 16,650 | $17.00 | $283,050 | 6,698,650 Direct | +0.25% | Acquired | 112.1% (price as of 2026-10-02) |
| Nov. 15, 2007 | CNK | P | 400 | $16.99 | $6,796 | 6,682,000 Direct | +0.01% | Acquired | 112.2% (price as of 2026-10-02) |
| Nov. 15, 2007 | CNK | P | 500 | $16.97 | $8,485 | 6,681,600 Direct | +0.01% | Acquired | 112.4% (price as of 2026-10-02) |
| July 30, 2007 | CNK | S | 378 | $16.50 | $6,237 | 6,681,100 Direct | +0.01% | Acquired | 118.5% (price as of 2026-10-02) |
| July 30, 2007 | CNK | S | 136 | $16.43 | $2,234 | 6,681,478 Direct | 0.00% | Disposed | 119.4% (price as of 2026-10-02) |
| July 30, 2007 | CNK | S | 75 | $16.41 | $1,231 | 6,681,614 Direct | 0.00% | Disposed | 119.7% (price as of 2026-10-02) |
| July 30, 2007 | CNK | S | 189 | $16.40 | $3,100 | 6,681,689 Direct | 0.00% | Disposed | 119.8% (price as of 2026-10-02) |
| July 30, 2007 | CNK | S | 377 | $16.35 | $6,164 | 6,681,878 Direct | -0.01% | Disposed | 120.5% (price as of 2026-10-02) |
| July 30, 2007 | CNK | S | 377 | $16.30 | $6,145 | 6,682,255 Direct | -0.01% | Disposed | 121.2% (price as of 2026-10-02) |
| July 30, 2007 | CNK | S | 1,132 | $16.25 | $18,395 | 6,682,632 Direct | -0.02% | Disposed | 121.8% (price as of 2026-10-02) |
| July 30, 2007 | CNK | S | 755 | $16.20 | $12,231 | 6,683,764 Direct | -0.01% | Disposed | 122.5% (price as of 2026-10-02) |
| July 30, 2007 | CNK | S | 377 | $16.15 | $6,089 | 6,684,519 Direct | -0.01% | Disposed | 123.2% (price as of 2026-10-02) |
| July 30, 2007 | CNK | S | 566 | $16.10 | $9,113 | 6,684,896 Direct | -0.01% | Disposed | 123.9% (price as of 2026-10-02) |
| July 30, 2007 | CNK | S | 566 | $16.05 | $9,084 | 6,685,462 Direct | -0.01% | Disposed | 124.6% (price as of 2026-10-02) |
| July 30, 2007 | CNK | S | 566 | $16.00 | $9,056 | 6,686,028 Direct | -0.01% | Disposed | 125.3% (price as of 2026-10-02) |
| July 30, 2007 | CNK | S | 566 | $15.95 | $9,028 | 6,686,594 Direct | -0.01% | Disposed | 126.0% (price as of 2026-10-02) |
| July 27, 2007 | CNK | P | 6,060 | $16.48 | $99,869 | 6,687,160 Direct | +0.09% | Acquired | 118.7% (price as of 2026-10-02) |
| July 24, 2007 | TCBIO | A | 2,000 | · | · | 4,000 Direct | +100.00% | Acquired | (price as of 2026-10-02) |
| July 24, 2007 | TCBIO | A | 500 | · | · | 17,700 Direct | +2.91% | Acquired | (price as of 2026-10-02) |
| May 16, 2007 | TCBIO | A | 100 | $22.49 | $2,249 | 17,700 Direct | +0.57% | Acquired | -16.0% (price as of 2026-10-02) |
| April 24, 2007 | CNK | P | 100 | $17.95 | $1,795 | 6,698,750 Direct | 0.00% | Acquired | 100.8% (price as of 2026-10-02) |
| May 16, 2006 | TCBIO | C | 100 | · | · | 400 Direct | -20.00% | Disposed | (price as of 2026-10-02) |
| May 16, 2006 | TCBIO | A | 2,000 | · | · | 2,000 Direct | · | Acquired | (price as of 2026-10-02) |
| May 16, 2006 | TCBIO | A | 500 | · | · | 500 Direct | · | Acquired | (price as of 2026-10-02) |
| May 17, 2005 | TCBIO | A | 4,000 | $19.37 | $77,480 | 20,000 Direct | +25.00% | Acquired | -2.4% (price as of 2026-10-02) |
| May 18, 2004 | TCBIO | A | 4,000 | $14.91 | $59,640 | 16,000 Direct | +33.33% | Acquired | 26.8% (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 19, 2011 | TCBIO | Stock Options | Common Stock | $7.25 | Jan. 1, 2012 | 4,000 | Disposed |
| Nov. 23, 2010 | TCBIO | Stock options | Common stock, par value $0.01 per share | $7.25 | Jan. 1, 2011 | 4,000 | Disposed |
| May 18, 2010 | TCBIO | Stock Appreciation Rights [F8] | Common Stock | $18.52 | May 18, 2020 | 3,000 | Acquired |
| May 19, 2009 | TCBIO | Stock Appreciation Rights | Common Stock | $14.17 | May 19, 2019 | 3,000 | Acquired |
| May 19, 2008 | TCBIO | Stock Appreciation Rights | Common Stock | $18.67 | May 19, 2018 | 3,000 | Acquired |
| May 19, 2008 | TCBIO | Stock Appreciation Rights | Common Stock | $18.67 | May 19, 2018 | 2,000 | Acquired |
| July 24, 2007 | TCBIO | Stock Appreciation Rights | Common Stock | $22.47 | July 24, 2017 | 2,000 | Acquired |
| May 16, 2006 | TCBIO | Restricted Stock Units | Common Stock | · | · | 100 | Disposed |
| May 16, 2006 | TCBIO | Stock Appreciation Rights | Common Stock | $23.00 | May 16, 2016 | 2,000 | Acquired |
| May 16, 2006 | TCBIO | Restricted Stock Units | Common Stock | · | · | 500 | Acquired |
| May 17, 2005 | TCBIO | Common Stock Options | Common Stock | $19.37 | May 17, 2015 | 4,000 | Acquired |
| May 18, 2004 | TCBIO | Common Stock Options | Common Stock | $14.91 | May 18, 2014 | 4,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2020 | $589,394 | · | $764,998 | · | $0 | · | $25,688 | $1,380,080 |
| 2019 | $1,000,001 | · | · | · | $1,414,002 | · | $24,089 | $2,438,092 |
| 2018 | $975,000 | · | · | · | $1,036,426 | · | $23,900 | $2,035,326 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.